OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,000 | -25.0% | 15,025 | 0.0% | 0.01% | -27.3% |
| Q1 2016 | $8,000 | -69.2% | 15,025 | 0.0% | 0.01% | -52.2% |
| Q4 2015 | $26,000 | -18.8% | 15,025 | 0.0% | 0.02% | -8.0% |
| Q3 2015 | $32,000 | -56.8% | 15,025 | 0.0% | 0.02% | -55.4% |
| Q2 2015 | $74,000 | -37.3% | 15,025 | 0.0% | 0.06% | -32.5% |
| Q1 2015 | $118,000 | +29.7% | 15,025 | 0.0% | 0.08% | +31.7% |
| Q4 2014 | $91,000 | – | 15,025 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |